References
- Barker, S. (2006). Nonsteroidal antiestrogens in the treatment of breast cancer. Curr Opin Investig Drugs. 7 (12):1085–1091.
- Barnadas, A., Gil, M., Sánchez-Rovira, P., Llombart, A., Adrover, E., Estevez, L. G., and et al (2008). Neoadjuvant endocrine therapy for breast cancer: past, present, and future. Anticancer Drugs. 19:339–347.
- Bernstein, P. S., DellaCroce, J. T. (2007). Diagnostic and therapeutic challenges. Tamoxifen toxicity. Retina. 27:982–988.
- Bhatia, A., Kumar, R., Katare, O. P. (2004). Tamoxifen-entrapped topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharma Sci. 7:252–259.
- Bhushan, S., Kumar, A., Malik, F., Andotra, S. S., Sethi, V. K., Kaur, I. P., and et al (2007). A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells. Apoptosis. 12:1911–1926.
- Bouwstra, J. A., De Graaff, A., Groenink, W., Honeywell, L. (2002). Elastic vesicles: interaction with human skin and drug transport. Cell Mol Biol Lett. 7:222–223.
- Chen, C. H., Liu, D. Z., Fang, H. W., Liang, H. J., Yang, T. S., Lin, S. Y. (2008). Evaluation of multitarget and single-target liposomal drugs for the treatment of gastric cancer. Biosci Biotechnol Biochem. 72:1586–1594.
- Choi, M. J., Maibach, H. I. (2005). Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci. 27:211–221.
- Geller, B. A., Vogel, V. G. (2005–2006). Chemoprevention of breast cancer in postmenopausal women. Breast Dis. 24:79–92.
- Huwyler, J., Drewe, J., Krähenbuhl, S. (2008). Tumor targeting using liposomal antineoplastic drugs. Int J Nanomedicine. 3:21–29.
- Jordan, V. C., Brodie, A. M. (2007). Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids. 72:7–25.
- Katare, O. P., Sinha, V. R., Bhatia, A., Kumar, R., Gupta, S. (2006). Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof. International patent publication. PCT No.: WO 2006/001035 A2.
- Lavie, O., Barnett-Griness, O., Narod, S. A., Rennert, G. (2008). The risk of developing uterine sarcoma after tamoxifen use. Int J Gynecol Cancer. 18:352–356.
- Lin, N. U., Winer, E. P. (2008). Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol. 26:798–805.
- Lúcio, M., Ferreira, H., Lima, J. L., Reis, S. (2007). Use of liposomes to evaluate the role of membrane interactions on antioxidant activity. Anal Chim Acta. 597:163–170.
- Machado, F., Rodríguez, J. R., León, J. P., Rodríguez, J. R., Parrilla, J. J., Abad, L. (2005). Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature. Eur J Gynaecol Oncol. 26:257–265.
- Neven, P., Van Den Broecke, R. (2007). Tamoxifen or aromatase inhibitors in breast cancer: efficacy and safety. Acta Chir Belg. 107:240–256.
- Spector, A. A., Yorek, M. A. (1985). Membrane lipid composition and cellular function. J Lipid Res. 26:1015–1035.
- Trif, M., Roseanu, A., Brock, J. H., Brewer, J. M. (2007). Designing lipid nanostructures for local delivery of biologically active macromolecules. J Liposome Res. 17 (3–4):237–248.
- van de Loosdrecht, A. A., Beelen, R. H., Ossenkoppele, G. J., Broekhoven, M. G., Langenhuijsen, M. M. (1994). A tetrazolium-based colorimetric MTT assay to quantitate human monocyte-mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Meth. 174 (1–2):311–320.
- Xi, X., Yang, F., Chen, D., Luo, Y., Zhang, D., Gu, N., Wu, J. (2008). A targeting drug-delivery model via interactions among cells and liposomes under ultrasonic excitation. Phys Med Biol. 53:3251–3265.